Momentum Indicators: RSI, MACD & Overbought/Oversold Status Currently, the Relative Strength Index (RSI) for GRCE stands at 64.45, which suggests a Neutral condition. Meanwhile, the MACD (12, 26) indicator is at 0.153, providing a Buy signal for short-term momentum. Other oscillators like the Stochastic Oscillator at 87.398 and the Commodity Channel Index (CCI) at 113.259 further confirm a 0.57 outlook for the stock.

Support, Resistance & Moving Averages From a structural perspective, GRCE is trading above its 60-day moving average of $3.618 and above its 200-day long-term moving average of $3.236. Key price levels to watch include the immediate resistance at $4.351 and strong support at $3.691. A break above $4.351 could signal a bull continuation, while falling below $3.691 may test the next Fibonacci floor at $3.336.

Grace Therapeutics, Inc (GRCE) Support & Resistance Level

Name	S3	S2	S1	Pivot Points	R1	R2	R3
Classic	3.031	3.336	3.691	3.996	4.351	4.656	5.011
Fibonacci	3.336	3.588	3.744	3.996	4.248	4.404	4.656

Grace Therapeutics, Inc (GRCE) Technical Indicators

2026-03-02

Name	Value
RSI_14	64.45
STOCHk_14_3_3	87.398
STOCHd_14_3_3	82.42
CCI_20	113.259
AO_5_34	0.368
MOM_10	0.57
MACD_12_26_9	0.153

Grace Therapeutics, Inc (GRCE) Relative Strength Index (RSI) is 64.45, creating a Neutral signal.

Grace Therapeutics, Inc (GRCE) Stochastic Oscillator is 87.398, creating a Sell signal.

Grace Therapeutics, Inc (GRCE) Stochastic RSI is 82.42, creating a Sell signal.

Grace Therapeutics, Inc (GRCE) Commodity Channel Index (CCI) is 113.259, creating a Sell signal.

Grace Therapeutics, Inc (GRCE) Awesome Oscillator is 0.368, creating a Buy signal.

Grace Therapeutics, Inc (GRCE) Momentum is 0.57, creating a Buy signal.

Grace Therapeutics, Inc (GRCE) MACD is 0.153, creating a Buy signal.

Grace Therapeutics, Inc (GRCE) Moving Average

2026-03-02

Period	Simple	Signal
MA_5	4.156	Buy
MA_10	4.047	Buy
MA_20	3.836	Buy
MA_60	3.618	Buy
MA_200	3.236	Buy
MA_250	3.071	Buy

Grace Therapeutics, Inc (GRCE) 5-Day simple moving average is 4.156, while Grace Therapeutics, Inc (GRCE) share price is $4.18, making it a Buy.

Grace Therapeutics, Inc (GRCE) 10-Day simple moving average is 4.047, while Grace Therapeutics, Inc (GRCE) share price is $4.18, making it a Buy.

Grace Therapeutics, Inc (GRCE) 20-Day simple moving average is 3.836, while Grace Therapeutics, Inc (GRCE) share price is $4.18, making it a Buy.

Grace Therapeutics, Inc (GRCE) 60-Day simple moving average is 3.618, while Grace Therapeutics, Inc (GRCE) share price is $4.18, making it a Buy.

Grace Therapeutics, Inc (GRCE) 200-Day simple moving average is 3.236, while Grace Therapeutics, Inc (GRCE) share price is $4.18, making it a Buy.

Grace Therapeutics, Inc (GRCE) 250-Day simple moving average is 3.071, while Grace Therapeutics, Inc (GRCE) share price is $4.18, making it a Buy.

People Also Watch

Frequently Asked Questions

What is the current technical consensus for GRCE?

The overall technical consensus for Grace Therapeutics, Inc (GRCE) is currently Strong Buy. This rating is derived from a combined analysis of moving averages and oscillators, currently showing 3 buy signals and 4 sell signals.

What are the key support and resistance levels for Grace Therapeutics, Inc (GRCE) today?

Based on pivot point calculations, Grace Therapeutics, Inc (GRCE) has an immediate support level at 3.691 and a major resistance level at 4.351. Traders also monitor the pivot point at 3.996 to determine the intraday trend direction.

Is Grace Therapeutics, Inc (GRCE) overbought or oversold based on the RSI?

The Relative Strength Index (RSI) for Grace Therapeutics, Inc (GRCE) is currently 64.45. This indicates that the stock is in neutral territory (typically, a value below 30 is oversold and above 70 is overbought).

What signal is the MACD providing for Grace Therapeutics, Inc (GRCE)?

Grace Therapeutics, Inc (GRCE) Moving Averages Convergence Divergence (MACD) indicator is 0.153, suggesting GRCE is Strong Buy. This indicator helps identify potential trend reversals or momentum shifts for Grace Therapeutics, Inc.

How is Grace Therapeutics, Inc (GRCE) performing relative to its 200-day moving average?

Grace Therapeutics, Inc (GRCE) is currently trading at $4.18, which is above its 200-day simple moving average of 3.236. Trading above the 200-day MA is often used by investors to determine the long-term bullish or bearish trend.

GRCE Technical

GRCE Technical

Technical Sentiment

Overall Consensus

Technical Analysis Consensus

Moving Average Consensus

Technical Analysis for GRCE